Maravai LifeSciences Holdings, Inc. (MRVI)
$6.53-7.51%Close
SELLCRISIS · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $947M
- Beta
- 0.60
- P/E (TTM)
- -12.19
- Short % float
- 13.67%
- Days to cover
- 5.9
- SI change
- +11.8%
- 1W
- -16.82%
- 1M
- -2.39%
- vs SPY 1W
- -16.68%
- vs SPY 1M
- -4.90%
Industry peers
FMP comparable companies · ranked by market cap
- TECHBUYBio-Techne Corporation$11.3BBULLQ 19$72.48-0.11%
- RGENSELLRepligen Corporation$9.9BBEARQ 26$175.42+1.69%
- BIOSELLBio-Rad Laboratories, Inc.$9.8BBEARQ 19$363.73-0.19%
- NEOGSELLNeogen Corporation$2.6BBEARQ 16$11.73-2.25%
- BLFSBUYBioLife Solutions, Inc.$1.9BBULLQ 11$38.61+0.00%
- AZTABUYAzenta, Inc.$1.7BRECOVERYQ 9$37.87+0.26%
- PACBBUYPacific Biosciences of California, Inc.$637MCRISISQ 4$2.05-2.38%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on MRVI?
- LOPJLB’s latest quantitative signal on Maravai LifeSciences Holdings, Inc. (MRVI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is MRVI in?
- Maravai LifeSciences Holdings, Inc. (MRVI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Maravai LifeSciences Holdings, Inc. (MRVI) do?
- Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases. Its diverse product line supports critical stages of biopharmaceutical development, featuring nucleic acids for both diagnostic and therapeutic applications, antibody…